Viewing Study NCT02710734


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-31 @ 11:01 AM
Study NCT ID: NCT02710734
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-24
First Post: 2016-02-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
Sponsor: Fox Chase Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module